The current pharmaceutical R&D model is broken. Broken because it denies one in three people access to drugs they need for life-threatening diseases like cancer, AIDS and hepatitis C, because it fails to invest in research on unprofitable diseases, because new drugs are sold at exorbitant prices that gamble with patients’ lives and jeopardize health system sustainability, and because it develops drugs with little therapeutic value, resulting in a waste of public resources and scientific knowledge.
It is an inefficient, unfair and unsustainable model based on protecting intellectual property over the right to health, opaque and hijacked by the private interests of large pharmaceutical companies. Which is why Salud por Derecho wants to change it.